← All organizations

Highest phase reached
Phase 4
First clinical trial
Nov 1, 2005Last known activity
Dec 31, 2025
Timeline
1990s
- Jul 1, 1993
Protalix— Founded
Drugs by trial phase (11 distinct, 27 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (40)
- NCT04552691Lead sponsorN/A—
- NCT07280156Lead sponsorPhase 2Dec 31, 2025
- NCT05745727Lead sponsorPhase 1Mar 23, 2023
- NCT03614234Lead sponsorPhase 3Nov 30, 2018
- NCT03566017Lead sponsorPhase 3Sep 30, 2018
- NCT03180840Lead sponsorPhase 3Dec 1, 2017
- NCT03180840Study directorPhase 3Dec 1, 2017
- NCT02921620Study directorPhase 3Jul 1, 2017
- NCT02921620Lead sponsorPhase 3Jul 1, 2017
- NCT03018730Study directorPhase 3Feb 23, 2017
- NCT03018730Lead sponsorPhase 3Feb 23, 2017
- NCT02768974Lead sponsorPhase 2Sep 1, 2016
- NCT02795676Study directorPhase 3Jun 1, 2016
- NCT02795676Lead sponsorPhase 3Jun 1, 2016
- NCT02722122Lead sponsorPhase 2May 1, 2016
Details
- Founded
- Carmiel, IL Jul 1, 1993
- Last known activity
- Dec 31, 2025